These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22093941)

  • 21. Optimization and validation of a fluorogenic dipeptidyl peptidase 4 enzymatic assay in human plasma.
    Yoon H; Cho SH; Seo YR; Yu KS; Park SS; Song MJ
    Anal Biochem; 2021 Jan; 612():113952. PubMed ID: 32926865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two commercial ELISAs against an in-house ELISA for measuring soluble CD26 in human serum.
    Ohnuma K; Saito T; Hatano R; Hosono O; Iwata S; Dang NH; Ninomiya H; Morimoto C
    J Clin Lab Anal; 2015 Mar; 29(2):106-11. PubMed ID: 24687574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of (arene)Ru(II) complexes of curcumin as inhibitors of dipeptidyl peptidase IV.
    Antonyan A; De A; Vitali LA; Pettinari R; Marchetti F; Gigliobianco MR; Pettinari C; Camaioni E; Lupidi G
    Biochimie; 2014 Apr; 99():146-52. PubMed ID: 24316375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors.
    Gattrell WT; Sambrook Smith CP; Smith AJ
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2464-9. PubMed ID: 22377519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
    Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY
    Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly lipophilic bicyclic nucleoside analogues.
    Diez-Torrubia A; Balzarini J; Andrei G; Snoeck R; De Meester I; Camarasa MJ; Velázquez S
    J Med Chem; 2011 Mar; 54(6):1927-42. PubMed ID: 21332170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV.
    Pascual I; Gómez H; Pons T; Chappé M; Vargas MA; Valdés G; Lopéz A; Saroyán A; Charli JL; de los Angeles Chávez M
    Int J Biochem Cell Biol; 2011 Mar; 43(3):363-71. PubMed ID: 21093607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible ligand release pathway of dipeptidyl peptidase IV investigated by molecular dynamics simulations.
    Li C; Shen J; Li W; Lu C; Liu G; Tang Y
    Proteins; 2011 Jun; 79(6):1800-9. PubMed ID: 21465558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipeptidyl peptidase IV (DPPIV/CD26)-based prodrugs of hydroxy-containing drugs.
    Diez-Torrubia A; Cabrera S; Lambeir AM; Balzarini J; Camarasa MJ; Velázquez S
    ChemMedChem; 2012 Apr; 7(4):618-28. PubMed ID: 22307932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
    Yazbeck R; Howarth GS; Abbott CA
    Trends Pharmacol Sci; 2009 Nov; 30(11):600-7. PubMed ID: 19837468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target-mediated metabolism and target-mediated drug disposition of the DPPIV inhibitor AMG 222.
    Greene RJ; Tu H; Gibbs JP; Greg Slatter J
    Xenobiotica; 2011 Nov; 41(11):945-57. PubMed ID: 21867423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitors.
    Zhu L; Li Y; Qiu L; Su M; Wang X; Xia C; Qu Y; Li J; Li J; Xiong B; Shen J
    ChemMedChem; 2013 Jul; 8(7):1104-16. PubMed ID: 23671024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site.
    Kühn-Wache K; Bär JW; Hoffmann T; Wolf R; Rahfeld JU; Demuth HU
    Biol Chem; 2011 Mar; 392(3):223-31. PubMed ID: 21284559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD26/DPPIV inhibition alters the expression of immune response-related genes in the thymi of NOD mice.
    Julián MT; Alonso N; Colobran R; Sánchez A; Miñarro A; Pujol-Autonell I; Carrascal J; Rodríguez-Fernández S; Ampudia RM; Vives-Pi M; Puig-Domingo M
    Mol Cell Endocrinol; 2016 May; 426():101-12. PubMed ID: 26911933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition.
    Nagakura T; Yasuda N; Yamazaki K; Ikuta H; Tanaka I
    Metabolism; 2003 Jan; 52(1):81-6. PubMed ID: 12524666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a robust QSAR model to predict the affinity of pyrrolidine analogs for dipeptidyl peptidase IV (DPP- IV).
    Paliwal S; Seth D; Yadav D; Yadav R; Paliwal S
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):129-40. PubMed ID: 21299434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity.
    Baerts L; Brouns R; Kehoe K; Verkerk R; Engelborghs S; De Deyn PP; Hendriks D; De Meester I
    Transl Stroke Res; 2017 Apr; 8(2):157-164. PubMed ID: 27561653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent, selective, and orally bioavailable quinoline-based dipeptidyl peptidase IV inhibitors targeting Lys554.
    Maezaki H; Banno Y; Miyamoto Y; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Sasaki M; Tsubotani S; Tani A; Funami M; Yamamoto Y; Tawada M; Aertgeerts K; Yano J; Oi S
    Bioorg Med Chem; 2011 Aug; 19(15):4482-98. PubMed ID: 21741847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of Highly Polar β-Homophenylalanine Derivatives as Nonsystemic Intestine-Targeted Dipeptidyl Peptidase IV Inhibitors.
    Huang F; Ning M; Wang K; Liu J; Guan W; Leng Y; Shen J
    J Med Chem; 2019 Dec; 62(23):10919-10925. PubMed ID: 31747282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorimetrical rate assay for urinary dipeptidyl peptidase IV (DPPIV) activity using a new substrate.
    Shibuya-Saruta H; Sugiyama M; Kasahara Y
    J Clin Lab Anal; 1995; 9(2):113-8. PubMed ID: 7714663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.